BioCentury
ARTICLE | Clinical News

Composite Cultured Skin regulatory update

February 26, 2001 8:00 AM UTC

ORTC received a humanitarian device exemption from the FDA to use its CCS in patients with Recessive Dystrophic Epidermolysis Bullosa (ulcerations of the hands and feet) undergoing hand reconstruction...